Please visit our main program website: Bing Center for Waldenstrom's Research. This site contains information on the latest treatment recommendations, abstracts, news and events, current and pending clinical trials and participating institutions, basic research, and publications, as well as photos and brief bios of the Bing Center staff.
WM Workshops: Starting with the first International Workshop for WM in Washington DC in Sept. 2000, worshops have been held bi-annually, the most recent in October of 2010 in Venice Italy. The next workshop is scheduled for August 2012 in Newport, RI (USA). These workshops provide a venue for the WM scientific community to collaborate and share their latest research with the goal of advancing the knowledge of the genetic basis and pathogenesis of WM, and the development of theraputics for this malignancy. To learn more, please visit our WM Workshop Website.
Patient/Physician Summits: Starting with the first summit in
Boston in November, 2001, these conferences have provided a valuable
opportunity for patients, their families and caregivers to meet
face-to-face with the leaders of the WM scientific community. They
can learn the latest developments in the research and treatment of
WM, and also participate in working sessions and panel discussions.
To learn more, please visit our WM
Summit Website.
Dedicated to the Discovery of the Cause and Cure of Waldenström’s Macroglobulinemia
Dr. Steven Treon is the Director of the Bing Center for Waldenström’s Research and an attending physician for medical oncology, at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, in Boston, Massachusetts. He is also an Associate Professor of Medicine at Harvard Medical School in Boston, and is the Chair of the Waldenström's Macroglobulinemia Clinical Trials Group.
After earning a doctorate in tumor immunology from Boston University (BU), Dr Treon did a postgraduate fellowship in the Department of Microbiology at BU School of Medicine. Dr Treon received a medical degree from BU School of Medicine and completed an internship in medicine and a residency in internal medicine at BU Medical Center. Dr Treon also served a clinical fellowship in hematology and oncology at Mass General Hospital and a research fellowship at Dana-Farber Cancer Institute and Harvard Medical School. He received certification from the American Board of Internal Medicine in 1995, and in medical oncology in 1997.
Dr Treon’s main research interests focus on understanding the genetic basis and pathogenesis of Waldenström’s macroglobulinemia and the development of therapeutics for this malignancy. He serves on the editorial boards of the Journal of Clinical Oncology, Blood, Clinical Cancer Research, and The Lancet. Dr Treon is a member of several professional societies including the American Medical Association, American Society of Hematology, American Society of Clinical Oncology, European Society of Hematology and the Massachusetts Medical Society. He has been honored with several research and academic awards from various national and international medical foundations and institutes, including the Robert A. Kyle Award for Waldenström's Macroglobulinemia.
Click this link to download a .pdf version of Dr. Treon's CV.
Featured News Items
NE Support Group Meeting: Feb 5, 2012, Dana-Farber Jimmy Fund Auditorium: Dr. Treon's presentation on Waldenstrom's Macroglobulinemia - Genetic Basis & Therapy. Click this link to view the lecture.
The 6th International Workshop on Waldenstrom's
Macroglobulinemia
(IWWM-6), was held on October 6-10, 2010, at the Molino Stucky Hilton hotel in beautiful historic Venice, Italy.
Close to 200 people attended the 3-day workshop, which included 17
sessions with 80 technical presentations from over 90 speakers,
including 14 young investigators, 5 guest presentations, 5 debates,
and 2 consensus panel discussions.
IWWM-6 was our most comprehensive meeting to date, and reflects the
continued growth in investigators working on the genetic basis,
pathogenesis, and treatment of WM. Since the IWWM began in 2000, the
number of participating investigators has steadily grown, as have
also the number of WM related publications including those arising
from the IWWM which have been published in Blood, Clinical Lymphoma
Myeloma, Haematologica, Journal of Clinical Oncology, and Seminars
in Oncology.
We hope the IWWM-6 has enriched each attendees understanding of
Waldenstrom's Macroglobulinemia, and will help foster discoveries
leading to its cure.
Dr. Anders Waldenström son of Dr. Jan Waldenström, presents to Dr. Treon at the Nobel Hall, Stockholm, Sweden (2008) the award his late father received from the International Society of Hematology (ISH) in 1956 in Boston, MA. Also, the cover of the March, 2009 "special issue" of Clinical Lymphoma & Myeloma (of which Dr. Treon is guest editor) and contains the reports from the 5th International Workshop on WM, October 15-19, Stockholm, Sweden. Please visit the Media page which contains these and other photos from our recent conferences and events.
